1. Kovaleva, Irina E, Tokarchuk, Artem V, Zheltukhin, Andrei O, Chumakov, Peter M, Budanov, Andrei V. 2020. Mitochondrial localization of SESN2. In PloS one, 15, e0226862. doi:10.1371/journal.pone.0226862. https://pubmed.ncbi.nlm.nih.gov/32287270/
2. Xu, Lingdan, Liu, Zelin, Wang, Huihui, Huang, Ke, Liu, Bin. 2023. SESN2 Could Be a Potential Marker for Diagnosis and Prognosis in Glioma. In Genes, 14, . doi:10.3390/genes14030701. https://pubmed.ncbi.nlm.nih.gov/36980973/
3. Wang, Binyang, Fu, Chenyang, Wei, Yuanyuan, Yin, Yong, Qin, Dongdong. 2022. Ferroptosis-related biomarkers for Alzheimer's disease: Identification by bioinformatic analysis in hippocampus. In Frontiers in cellular neuroscience, 16, 1023947. doi:10.3389/fncel.2022.1023947. https://pubmed.ncbi.nlm.nih.gov/36467613/
4. Zheng, Ting, Zhang, Ding, Fu, Qingzhen, Liu, Jinyin, Zhao, Yashuang. 2024. DNA methylation-driven gene FAM3D promotes colorectal cancer growth via the ATF4-SESN2-mTORC1 pathway. In Aging, 16, 12866-12892. doi:10.18632/aging.206115. https://pubmed.ncbi.nlm.nih.gov/39388305/
5. Wang, Panxia, Wang, Minghui, Hu, Yuehuai, Lu, Jing, Liu, Peiqing. 2020. Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression. In Acta pharmaceutica Sinica. B, 11, 680-693. doi:10.1016/j.apsb.2020.10.017. https://pubmed.ncbi.nlm.nih.gov/33777675/